- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 39/23 - Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
Patent holdings for IPC class C07C 39/23
Total number of patents in this class: 454
10-year publication summary
15
|
12
|
27
|
56
|
129
|
88
|
79
|
28
|
40
|
6
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
HEXO Operations Inc. | 192 |
31 |
Canopy Growth Corporation | 221 |
25 |
Pike Therapeutics Inc. | 39 |
15 |
Cardiol Therapeutics Inc. | 22 |
13 |
Emerald Health Therapeutics Canada Inc. | 19 |
10 |
Jazz Pharmaceuticals Research UK Limited | 220 |
10 |
Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1349 |
6 |
Avicanna Inc. | 41 |
6 |
PurCann Pharma Inc. | 17 |
6 |
Kare Chemical Technologies Inc. | 26 |
6 |
Emory University | 1631 |
5 |
Enantia, S.L. | 20 |
5 |
GW Research Limited | 193 |
5 |
Canntab Therapeutics Limited | 12 |
5 |
Nextleaf Solutions Ltd. | 39 |
5 |
Bessor Pharma, LLC | 12 |
5 |
SCF Pharma Inc. | 30 |
4 |
The University of British Columbia | 1502 |
4 |
Kazmira, LLC | 13 |
4 |
Nalu bio, Inc. | 6 |
4 |
Other owners | 280 |